Page last updated: 2024-11-06

lysergic acid diethylamide and Lymphoma, Non-Hodgkin

lysergic acid diethylamide has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SCOTT, KG1
DANIELS, AE1

Other Studies

1 other study available for lysergic acid diethylamide and Lymphoma, Non-Hodgkin

ArticleYear
THE SIMILAR ACTION OF LYSERGIC ACID DERIVATIVES, HYPERTENSIN (CIBA) AND ALDOSTERONE UPON RB86 UPTAKE BY RED BLOOD CELLS FROM CONTROL AND CANCER SUBJECTS.
    Proceedings of the Western Pharmacology Society, 1963, Volume: 6

    Topics: Adenocarcinoma; Aldosterone; Angiotensin Amide; Angiotensins; Carcinoma, Squamous Cell; Erythrocytes

1963